thyssenkrupp nucera reported a return to profitability in the 2024/2025 fiscal year despite experiencing a slight decline in sales, according to preliminary unaudited figures. The electrolysis technology specialist achieved earnings before interest and taxes of approximately EUR 2 million, a significant improvement from the negative EUR 14 million reported in the previous fiscal year. Sales reached EUR 845 million, slightly below the previous year's EUR 862 million and falling short of the company's original forecast range of EUR 850 million to EUR 920 million.
The company's performance varied significantly between its two main business segments. The Green Hydrogen segment, which utilizes alkaline water electrolysis technology to produce climate-neutral hydrogen, saw sales decline to EUR 459 million from EUR 524 million in the previous year. However, this segment showed substantial improvement in its financial performance, with EBIT improving to negative EUR 56 million from negative EUR 76 million. In contrast, the Chlor-Alkali segment experienced double-digit sales growth, reaching EUR 386 million compared to EUR 338 million in the prior year, though EBIT declined slightly to EUR 58 million from EUR 62 million.
Order intake presented concerning trends for future performance, totaling EUR 348 million compared to EUR 636 million in the previous fiscal year. The Green Hydrogen segment accounted for only EUR 26 million of new orders, a dramatic decrease from EUR 356 million in the prior year. The order backlog as of September 30, 2025, stood at EUR 0.6 billion, down from EUR 1.1 billion in the previous year. The company maintained positive free cash flow and continues to finance its operations through business activities.
Looking ahead to the 2025/2026 fiscal year, the Management Board anticipates significant challenges. Consolidated sales are projected to decline to between EUR 500 million and EUR 600 million, while EBIT is expected to range from negative EUR 30 million to break-even. CEO Dr. Werner Ponikwar attributed the challenging outlook to increased market difficulties for green hydrogen, continued restraint in final investment decisions, and a deteriorating global economic environment. The company has initiated measures to reduce the impact of lower sales on cost coverage and earnings.
Detailed explanations of the financial performance indicators used can be found in thyssenkrupp nucera's 2023/2024 Annual Report on pages 53 to 54. The company will publish comprehensive fourth quarter and full-year 2024/2025 results along with detailed forecasts for the 2025/2026 fiscal year in its annual report on December 17, 2025. Despite the challenging market conditions, management expressed confidence in the company's positioning in hydrogen and chlor-alkali markets and its financial resilience to navigate current difficulties while pursuing strategic goals.
